Lincomycin is a lincosamide antibiotic that comes from the actinomycete Streptomyces lincolnensis. A related compound, clindamycin, is derived from lincomycin by using thionyl chloride to replace the 7-hydroxy group with a chlorine atom with inversion of chirality. It was released for medical use in September 1964..
The current European Maximum Residue Limit for Lincomycin is set at 150μg/kg in bovine milk according to EU Council Regulation EEC No.2377/90 and its amendments.
This product is a mouse monoclonal antibody against lincomycin drug, which can be used in immunoassay for the detection of lincomycin drug in various biological samples.
ELISA, lateral flow immunoassay and other immunoassays.
to be listed.
Sending to firstname.lastname@example.org for details.